The National Institute of Allergy and Infectious Diseases (NIAID) today announced a new program that will quickly pay $ 6 million in grants pursue risky new ideas for a vaccine against AIDS. NIAID hope this cash injection will rev a field that has all but stalled.
The new funding mechanism, called the Innovation Grants Program for research approaches to HIV vaccine is the first realization of the vaccine against the AIDS Research Committee (AVRC), a group led by Nobel Prize David Baltimore, the Massachusetts Institute of Technology. At its first meeting on 17 February, the committee discussed what was broken in the vaccine research system that could help solve. "Part of what they saw as broken is that there is not enough of an opportunity to do research on vaccines that will through the system in a timely manner," says Carole Heilman NIAID, which is overseeing innovation.
the grants, each of whom will pay $ 150,000 in direct costs for 2 years, will fund research in three key areas. the first is a better understanding of protein surface of the AIDS virus, HIV Although this issue has been studied extensively, AVRC Norman Letvin member of Harvard Medical School says that critical gaps exist, such as the development of monoclonal antibodies that work against natural -. not only genetically. - versions of the protein AVRC would also like to see more work on the development of better animal models that Heilman said could include the application of new techniques used in the now famous lamb cloning experiments to develop a genetically population identical test animals. The third objective will be to maximize the immune response of the body against HIV by using different strategies for presenting pieces of the virus to the immune system.
Grant Proposals are due May 23, and NIAID will make September 30 price.
0 Komentar